Total Ankle Replacement XX

Transcription

1 Total Ankle Replacement XX Current and Future Players XX XXX / Published XXX GDME1004FPR / Published February 2013

2 1 Table of Contents 1 Table of Contents List of Tables List of Figures Introduction Catalyst Related Reports Competitive Assessment Overview Competitive Assessment Two-Component Fixed-Bearing Agility LP Salto Talaris INBONE II TNK Zimmer Trabecular Metal Total Ankle Three-Component Mobile-Bearing Scandinavian Total Ankle Replacement (STAR) Mobility Salto HINTEGRA BOX (Bologna-Oxford) Zenith CCI Evolution Pipeline Products Overview INBONE II Total Ankle with Calcaneal Stem Fixation Overview Page 2 GDME1004FPR / Published FEB 2013

3 4.2.2 SWOT Analysis Akilos Total Ankle System Overview SWOT Analysis Current and Future Players Overview Trends in Corporate Strategy Company Profiles Small Bone Innovation, Inc DePuy Synthes Tornier N.V Wright Medical Group, Inc Integra LifeSciences Zimmer Holdings, Inc Corin Group KYOCERA Medical Corporation MatOrtho Implants International Other Companies Appendix Abbreviations Bibliography Methodology Coverage Secondary Research Primary Research Forecasting Methodology Physicians and Specialists Included in this Study Page 3 GDME1004FPR / Published FEB 2013

4 6.5 Physician Survey About the Authors Analysts Global Head of Healthcare About MediPoint About GlobalData Contact Us Disclaimer Page 4 GDME1004FPR / Published FEB 2013

5 1.1 List of Tables Table 1: Currently Marketed Total Ankle Replacement Implants Table 2: Product Profile Agility LP Table 3: SWOT Analysis Agility LP Table 4: Product Profile Salto Talaris Table 5: SWOT Analysis Salto Talaris Table 6: Product Profile INBONE II Table 7: SWOT Analysis INBONE II Table 8: Product Profile TNK Table 9: SWOT Analysis TNK Table 10: Product Profile Zimmer Trabecular Metal Total Ankle Table 11: SWOT Analysis - Zimmer Trabecular Metal Total Ankle Table 12: Product Profile STAR Table 13: SWOT Analysis STAR Table 14: Product Profile Mobility Table 15: SWOT Analysis Mobility Table 16: Product Profile Salto Table 17: SWOT Analysis Salto Table 18: Product Profile HINTEGRA Table 19: SWOT Analysis HINTEGRA Table 20: Product Profile BOX Table 21: SWOT Analysis BOX Table 22: Product Profile Zenith Table 23: SWOT Analysis Zenith Table 24: Product Profile CCI Evolution Table 25: SWOT Analysis CCI Evolution Table 26: Product Profile INBONE II Total Ankle with Calcaneal Stem Fixation Table 27: SWOT Analysis of INBONE II Total Ankle with Calcaneal Stem Fixation Page 5 GDME1004FPR / Published FEB 2013

6 Table 28: Product Profile Akilos Table 29: SWOT Analysis Akilos Table 30: Company Profile Small Bone Innovations Table 31: Portfolio Assessment Small Bone Innovations, Table 32: SBi s Foot and Ankle Business SWOT Analysis, Table 33: Company Profile DePuy Synthes Companies Table 34: DePuy's Total Ankle Replacement Portfolio Assessment, Table 35: DePuy's Foot and Ankle Business SWOT Analysis, Table 36: Company Profile Tornier N.V Table 37: Tornier's Total Ankle Replacement Portfolio Assessment, Table 38: Tornier's Foot and Ankle Business SWOT Analysis, Table 39: Company Profile Wright Medical Group Table 40: Wright Medical's Total Ankle Replacement Portfolio Assessment, Table 41: Wright Medical's Foot and Ankle Business SWOT Analysis, Table 42: Company Profile Integra LifeSciences Table 43: Integra's Total Ankle Replacement Portfolio Assessment, Table 44: Integra's Foot and Ankle Business SWOT Analysis, Table 45: Company Profile Zimmer Holdings Table 46: Zimmer Holding s Total Ankle Replacement Portfolio Assessment, Table 47: Zimmer's Foot and Ankle Business SWOT Analysis, Table 48: Company Profile Corin Group Table 49: Corin Group's Total Ankle Replacement Portfolio Assessment, Table 50: Corin Group's Foot and Ankle Business SWOT Analysis, Table 51: Company Profile KYOCERA Medical Corporation Table 52: KYOCERA Medical's Total Ankle Replacement Portfolio Assessment, Table 53: KYOCERA Medical's Orthopedic Devices Business SWOT Analysis, Table 54: Company Profile - MatOrtho Table 55: MatOrtho's Total Ankle Replacement Portfolio Assessment, Page 6 GDME1004FPR / Published FEB 2013

7 Table 56: MatOrtho's Orthopedic Devices Business SWOT Analysis, Table 57: Company Profiles Implants International Table 58: Implants International's Total Ankle Replacement Portfolio Assessment, Table 59: Implants International's Orthopedic Devices Business SWOT Analysis, Table 60: Portfolio Assessment Other Players in Total Ankle Replacement Market, Table 61: Abbreviations Table 62: Physicians Surveyed, By Country Page 7 GDME1004FPR / Published FEB 2013

8 1.2 List of Figures Figure 1: Estimated Global Market for TAR Implants in Figure 2: Product Image Agility LP Figure 3: Product Image Salto Talaris Figure 4: Product Image INBONE II Figure 5: Product Image TNK Figure 6: Product Image Zimmer Trabecular Metal Total Ankle Figure 7: Product Image STAR Figure 8: Product Image Mobility Figure 9: Product Image Salto Figure 10: Product Image HINTEGRA Figure 11: Product Image BOX Figure 12: Product Image Zenith Figure 13: Product Image CCI Evolution Figure 14: Product Image Akilos Page 8 GDME1004FPR / Published FEB 2013

9 Introduction 2 Introduction With a much lower incidence of arthritis, the ankle joint enjoys a unique biological resilience to the degenerative process that routinely plagues the hips and the knees. Nonetheless, the ankle joint is still susceptible to arthritis, mostly in the form of post-traumatic arthritis. Total ankle replacement (TAR) enables implantation of prosthesis within the diseased native ankle joint to help patients maintain their ankles range of motion. Early experience with TAR in the US and Europe was met with unacceptable failure and complication rates in the 1980s, such that the procedure was largely abandoned. In the past decade, newer generations of TAR prostheses with a more anatomical replication of the ankle joint demonstrated some encouraging early and medium-term clinical results. Meanwhile, long-term results following successful early ankle fusion have brought to light somewhat disappointing long-term satisfaction rates. TAR is becoming an increasingly popular alternative to ankle fusion lately, as professional and commercial interest intensifies and long-term effectiveness becomes available. As more competitors enter the market and the indications of TAR have been suggested to expand to include younger patients and those with some hindfoot deformities, surgeon adoption will further increase and this industry will enjoy steady growth in coming years, especially in emerging markets. 2.1 Catalyst TAR represents a promising option for late-stage ankle arthritis patients as an alternative to ankle fusion, which has historically been presumed to be the gold-standard procedure. Clinical longevity of TAR hinges on the availability of its long-term clinical efficacy, improved patient awareness, and updated insurance policies, as well as suppliers efforts on shortening the steep learning curve presented to surgeons. This report focuses on TAR market in 10 countries: the US, France, Germany, Italy, Spain, the UK, Japan, Brazil, China and India. GlobalData identified currently marketed TAR prostheses, evaluated the unmet needs in the market and provided an understanding of surgeon perception of TAR within the global foot and ankle community. According to our analysis, widespread adoption of TAR will be realized in the US, Europe and Japan in the next few years, but will be slower in China, India and Brazil, although the emerging markets are expected to grow at a higher CAGR throughout the forecast period. To successfully capitalize within the global TAR market, companies need to provide deliverables adopting better design philosophies that address the current unmet needs, and to put more energy into clinical education to drive surgeon adoption. Page 9 GDME1004FPR / Published FEB 2013

10 Appendix 6.7 About MediPoint MediPoint is the flagship product for GlobalData s Medical team. Each MediPoint report is built from the ground-up by our team of healthcare analysts in the US and UK. Each report includes input from experienced physicians and leading Key Opinion Leaders (KOL). Running throughout each report in the series, What Physicians Think quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. 6.8 About GlobalData GlobalData is a leading global provider of business intelligence in the Healthcare industry. GlobalData provides its clients with up-to-date information and analysis on the latest developments in drug research, disease analysis, and clinical research and development. Our integrated business intelligence solutions include a range of interactive online databases, analytical tools, reports and forecasts. Our analysis is supported by a 24/7 client support and analyst team. GlobalData has offices in New York, Boston, London, India and Singapore. Page 77 GDME1004FPR / Published FEB 2013

11 Appendix 6.10 Disclaimer All Rights Reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise without the prior permission of the publisher, GlobalData. Page 78 GDME1004FPR / Published FEB 2013